Danhof Nora A, Kamphuis Esme I, Limpens Jacqueline, van Lonkhuijzen Luc R C W, Pajkrt Eva, Mol Ben W J
Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands.
Obstetrics and Gynaecology, Academic Medical Centre, Amsterdam, The Netherlands.
Eur J Obstet Gynecol Reprod Biol. 2015 May;188:24-33. doi: 10.1016/j.ejogrb.2015.02.033. Epub 2015 Mar 2.
Cervical surgery is associated with preterm birth (PTB) and neonatal morbidity. However, it is unknown whether this increased risk is due to the surgery itself or to the cervical intraepithelial neoplasia (CIN) underlying the surgery. Our objective was to assess the risk for PTB in women with treated and untreated CIN. We performed an electronic literature search in MEDLINE, Embase and CENTRAL for studies that reported on pregnancy outcome after treated and untreated CIN. The methodological quality was scored using the STROBE combined checklist for observational studies. We extracted data on PTB<37 weeks, very PTB<32 weeks, spontaneous PTB<37 weeks, (preterm) premature rupture of membranes ((P)PROM), perinatal mortality and section caesarean each before and after treatment for CIN. We used the Mantel-Haenszel method to estimate summarizing odds ratios. Our search identified 620 studies, of which 20 were reporting on pregnancy outcome for a total of 12,159,293 women. There were 20,832 women who gave birth after treatment for CIN before pregnancy, 52 women who gave birth after treatment for CIN during pregnancy, 64,237 women with CIN who gave birth before treatment, and 8,902,865 women who gave birth without CIN. Compared to women with untreated CIN, women treated for CIN before or during pregnancy, had a significantly higher risk of PTB<37 weeks (OR 1.7, 95% CI 1.0-2.7). When comparing women treated for CIN before pregnancy (n=20,832) to women with untreated CIN (n=64,162), we found an OR of 1.4 with a 95% confidence interval of 0.85-2.3. Women treated during pregnancy had a clearly increased risk for PTB (OR 6.5, 95% CI 1.1-37), and (P)PROM (OR 1.8, 95% CI 1.4-2.2). In women with cervical surgery, the risks for spontaneous PTB<37 weeks (OR 0.87, 95% CI 0.54-1.4), caesarean section (OR 1.0, 95% CI 0.71-1.5) and perinatal mortality (OR 1.0, 95% CI 0.38-2.8) were not increased. The increased risk of PTB in women who underwent cervical surgery for CIN is especially increased when performed during pregnancy. When performed before pregnancy the risk of PTB is increased, although insignificant.
宫颈手术与早产(PTB)及新生儿发病有关。然而,这种风险增加是由于手术本身还是手术背后的宫颈上皮内瘤变(CIN)尚不清楚。我们的目的是评估接受和未接受CIN治疗的女性发生PTB的风险。我们在MEDLINE、Embase和CENTRAL中进行了电子文献检索,以查找报告接受和未接受CIN治疗后妊娠结局的研究。使用STROBE观察性研究综合清单对方法学质量进行评分。我们提取了CIN治疗前后37周前PTB、32周前极早早产、37周前自发性PTB、(早产)胎膜早破((P)PROM)、围产期死亡率及剖宫产的数据。我们使用Mantel-Haenszel方法来估计汇总比值比。我们的检索共识别出620项研究,其中20项报告了12159293名女性的妊娠结局。有20832名女性在妊娠前接受CIN治疗后分娩,52名女性在妊娠期间接受CIN治疗后分娩,64237名患有CIN的女性在治疗前分娩,8902865名无CIN的女性分娩。与未接受CIN治疗的女性相比,在妊娠前或妊娠期间接受CIN治疗的女性发生37周前PTB的风险显著更高(比值比1.7,95%置信区间1.0 - 2.7)。当比较妊娠前接受CIN治疗的女性(n = 20832)与未接受CIN治疗的女性(n = 64162)时,我们发现比值比为1.4,95%置信区间为0.85 - 2.3。妊娠期间接受治疗的女性发生PTB(比值比6.5,95%置信区间1.1 - 37)及(P)PROM(比值比1.8,95%置信区间1.4 - 2.2)的风险明显增加。在接受宫颈手术的女性中,37周前自发性PTB(比值比0.87,95%置信区间0.54 - 1.4)、剖宫产(比值比1.0,95%置信区间0.71 - 1.5)及围产期死亡率(比值比1.0,95%置信区间0.38 - 2.8)的风险并未增加。因CIN接受宫颈手术的女性发生PTB的风险增加,在妊娠期间进行手术时尤其明显。在妊娠前进行手术时,PTB风险增加,尽管不显著。